ALPCO Diagnostics-医療機器分野:企業M&A・提携分析

◆英語タイトル:ALPCO Diagnostics - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012908
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ALPCO Diagnostics (ALPCO) is a lifescience company that imports and distributes immunoassay based products. The company’s products include immunoassays, chemiluminescent assays, flow cytometry reagents, purified antibodies, recombinant proteins, and HPLC and MS-MS reagents. It also provides food additives, acute leukemia orientation tube, vitamins, anti bovine growth hormone, multi-epitope antibody, and others. ALPCO’s products are used for therapeutic areas including antibodies and antigens, bone metabolism, allergy and infectious disease, endocrinology, diabetes and obesity, toxicology and neurobiology. The company’s stellux is a chemiluminescent assay platform. It markets its products through a network of distributors located across the world. ALPCO is headquartered in Salem, New Hampshire, the US.

ALPCO Diagnostics – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ALPCO Diagnostics, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
ALPCO Diagnostics, Medical Equipment Deals By Type, 2011 to YTD 2017 6
ALPCO Diagnostics, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
ALPCO Diagnostics, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
ALPCO Diagnostics, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
ALPCO Diagnostics, Medical Equipment, Deal Details 10
Partnerships 10
Euro Diagnostica Enters Into Distribution Agreement With Alpco Diagnostics For Assay Portfolio 10
BioCat Enters Into Distribution Agreement With Alpco Diagnostics For ELISA Kits 11
WILEX Enters Into Co-Marketing Agreement With ALPCO Diagnostics 12
ALPCO Diagnostics – Key Competitors 13
ALPCO Diagnostics – Key Employees 14
ALPCO Diagnostics – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
ALPCO Diagnostics, Medical Equipment, Key Facts 2
ALPCO Diagnostics, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
ALPCO Diagnostics, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
ALPCO Diagnostics, Medical Equipment Deals By Type, 2011 to YTD 2017 6
ALPCO Diagnostics, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
ALPCO Diagnostics, Deals By Market, 2011 to YTD 2017 8
ALPCO Diagnostics, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Euro Diagnostica Enters Into Distribution Agreement With Alpco Diagnostics For Assay Portfolio 10
BioCat Enters Into Distribution Agreement With Alpco Diagnostics For ELISA Kits 11
WILEX Enters Into Co-Marketing Agreement With ALPCO Diagnostics 12
ALPCO Diagnostics, Key Competitors 13
ALPCO Diagnostics, Key Employees 14

★海外企業調査レポート[ALPCO Diagnostics-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AbGenomics International Inc-製薬・医療分野:企業M&A・提携分析
    Summary AbGenomics International Inc (AbGenomics) is a biopharmaceutical company that develops therapeutics for inflammatory diseases and cancers. The company provides products such as pipeline products, monoclonal antibody products, therapeutic products, neihulizumab, bio-therapeutics, and biobette …
  • Gran Tierra Energy Inc (GTE):石油・ガス:M&Aディール及び事業提携情報
    Summary Gran Tierra Energy Inc (Gran Tierra) is an independent energy company. It acquires, explores, and develops oil and gas fields. The company produces crude oil, natural gas, and oil equivalent resources from its fields. Gran Tierra has onshore oil and gas properties in Colombia. It sells oil t …
  • MISC Bhd (MISC):企業の財務・戦略的SWOT分析
    MISC Bhd (MISC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Gol Linhas Aereas Inteligentes SA :企業の戦略・SWOT・財務情報
    Gol Linhas Aereas Inteligentes SA - Strategy, SWOT and Corporate Finance Report Summary Gol Linhas Aereas Inteligentes SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • SOM Biotech SL:製薬・医療:M&Aディール及び事業提携情報
    Summary SOM Biotech SL (SOM Biotech) is a drug repurposing company that discovers and develops new drugs for orphan indications. The company’s pipeline products include SOM0777, SOM0226, SOM3355, SOM1201 and SOM2201 are used for the treatment of TTR amyloidosis, glioblastoma, huntington disease, duc …
  • SOL SpA (SOL):企業の財務・戦略的SWOT分析
    Summary SOL SpA (SOL), a subsidiary of Gas and Technologies World BV, is engaged in research, produces and distributes industrial, pure, technical, and medicinal gases. The company’s technical gases include nitrogen, oxygen, hydrogen, carbon dioxide, argon, nitrous oxide, acetylene, medical gases, g …
  • New Zealand Oil & Gas Ltd (NZO):企業の財務・戦略的SWOT分析
    Summary New Zealand Oil & Gas Ltd (NZOG) is an oil and gas that offers oil and gas exploration, development and production. The company acquires, explores, and develops crude oil and natural gas properties. Its producing assets include Maari and Manaia fields, Kupe gas and light oil field, and Sampa …
  • Saxo Bank A/S:企業のM&A・事業提携・投資動向
    Saxo Bank A/S - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Saxo Bank A/S Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • PharmAbcine Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary PharmAbcine Inc (PharmAbcine) is a biotechnology company that discovers and develops human therapeutic monoclonal antibodies. The company offers products such as bi-specific MAB and lead MAB products. It provides services such as binding test by ELISA, screening by ELISA, mono-phage Ab seque …
  • Photocure ASA (PHO):企業の財務・戦略的SWOT分析
    Photocure ASA (PHO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Country Road Group Pty Ltd:企業の戦略的SWOT分析
    Country Road Group Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • A. O. Smith Corporation:企業の戦略・SWOT・財務情報
    A. O. Smith Corporation - Strategy, SWOT and Corporate Finance Report Summary A. O. Smith Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Electricite de France SA:発電所・企業SWOT分析
    Electricite de France SA - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key empl …
  • Tizona Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tizona Therapeutics Inc (Tizona Therapeutics) is an immunology company which develops treatments for cancer and autoimmune disorders. Its lead product candidate anti-CD39 antibody inhibits the breakdown of excessive ATP released from dying tumor cells to immune suppressive adenosine leading …
  • Grohe AG:企業の戦略的SWOT分析
    Grohe AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • China Biologic Products Inc (CBPO):企業の財務・戦略的SWOT分析
    China Biologic Products Inc (CBPO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Virbac Corporation
    Virbac Corporation - Strategy, SWOT and Corporate Finance Report Summary Virbac Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Lukoil Oil Co (LKOH):企業の財務・戦略的SWOT分析
    Lukoil Oil Co (LKOH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Emerald Health Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Emerald Health Sciences Inc (EHS) focuses to advance the development of cannabis in pharmaceutical, botanical and bioceutical applications. The company is developing EHP-101 based on cannabidiol for the treatment of multiple sclerosis (MS) and scleroderma; and EHP-102, derived from cannabige …
  • Alarko Contracting Group:企業の戦略・SWOT・財務分析
    Alarko Contracting Group - Strategy, SWOT and Corporate Finance Report Summary Alarko Contracting Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆